{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:58:26Z","timestamp":1784095106600,"version":"3.55.0"},"posted":{"date-parts":[[2026,1,27]]},"group-title":"Immunology","reference-count":67,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["R01 AI161803"],"award-info":[{"award-number":["R01 AI161803"]}]},{"name":"NIH","award":["R01 AI183381"],"award-info":[{"award-number":["R01 AI183381"]}]},{"name":"NIH","award":["T32AI007290"],"award-info":[{"award-number":["T32AI007290"]}]},{"name":"NIH","award":["T32 AI007502"],"award-info":[{"award-number":["T32 AI007502"]}]},{"DOI":"10.13039\/100000097","name":"NCRR","doi-asserted-by":"crossref","award":["1S10OD032300-01"],"award-info":[{"award-number":["1S10OD032300-01"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Targeting the HIV-infected reservoir in lymphoid tissues (LT) will be critical to developing a cure for people living with HIV (PLWH). LT explants used to study HIV infection enable the evaluation of human-specific disease progression and treatment response; however, their short lifespan makes it challenging to assess long-term treatment interventions. We therefore established an immune organoid model of HIV infection using human tonsil or spleen cells, demonstrating productive HIV infection and viral integration into CD4\n                  <jats:sup>+<\/jats:sup>\n                  T cells. Treatment with a protease inhibitor fully suppressed ongoing viral production, with virologic rebound occurring within days of treatment interruption. The transfer of healthy allogeneic NK cells to target the reservoir upon treatment interruption reduced the number of infected cells, intact viral genomes, and production of\n                  <jats:italic>de novo<\/jats:italic>\n                  infectious viral particles. Adoption of this immune organoid platform will accelerate the evaluation of cure-based strategies to eliminate the HIV reservoir in tissues for PLWH.\n                <\/jats:p>","DOI":"10.64898\/2026.01.25.701611","type":"posted-content","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:35:12Z","timestamp":1769571312000},"source":"Crossref","is-referenced-by-count":1,"title":["Modeling HIV infection, treatment, rebound, and intervention in human immune organoids"],"prefix":"10.64898","author":[{"given":"Sarah A.","family":"Sackey","sequence":"first","affiliation":[{"name":"Stanford Immunology Program, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E.","family":"Schrum","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma M.","family":"Mangalanathan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Fish","sequence":"additional","affiliation":[{"name":"Division of Human Biology, Fred Hutch Cancer Center, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Sola","sequence":"additional","affiliation":[{"name":"Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Selehi","sequence":"additional","affiliation":[{"name":"Donor Network West, San Ramon, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Pi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome A.","family":"Zack","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California, USA"},{"name":"Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn T.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara A.","family":"Lehman","sequence":"additional","affiliation":[{"name":"Division of Human Biology, Fred Hutch Cancer Center, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Stanford Immunology Program, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Blish","sequence":"additional","affiliation":[{"name":"Stanford Immunology Program, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Chan Zuckerberg Biohub, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026020503293834000_2026.01.25.701611v1.1","unstructured":"HIV data and statistics. https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics."},{"key":"2026020503293834000_2026.01.25.701611v1.2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.21.9838"},{"key":"2026020503293834000_2026.01.25.701611v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/362355a0"},{"key":"2026020503293834000_2026.01.25.701611v1.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501263320402"},{"key":"2026020503293834000_2026.01.25.701611v1.5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134815"},{"key":"2026020503293834000_2026.01.25.701611v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4411"},{"key":"2026020503293834000_2026.01.25.701611v1.7","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905280-00001"},{"key":"2026020503293834000_2026.01.25.701611v1.8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.26.15109"},{"key":"2026020503293834000_2026.01.25.701611v1.9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab541"},{"key":"2026020503293834000_2026.01.25.701611v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56116-1"},{"key":"2026020503293834000_2026.01.25.701611v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4113"},{"key":"2026020503293834000_2026.01.25.701611v1.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318249111"},{"key":"2026020503293834000_2026.01.25.701611v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/387183a0"},{"key":"2026020503293834000_2026.01.25.701611v1.14","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5341.1295"},{"key":"2026020503293834000_2026.01.25.701611v1.15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00553-16"},{"key":"2026020503293834000_2026.01.25.701611v1.16","doi-asserted-by":"crossref","first-page":"e0307821","DOI":"10.1128\/mBio.03078-21","article-title":"Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy","volume":"12","year":"2021","journal-title":"MBio"},{"key":"2026020503293834000_2026.01.25.701611v1.17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.celrep.2015.08.011","article-title":"Cell-to-cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid-tissue-derived CD4 T cells","volume":"12","year":"2015","journal-title":"Cell Rep"},{"key":"2026020503293834000_2026.01.25.701611v1.18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.5.1058"},{"key":"2026020503293834000_2026.01.25.701611v1.19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2367"},{"key":"2026020503293834000_2026.01.25.701611v1.20","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.3390\/ijms232315380","article-title":"In vitro susceptibility of HIV isolates with high growth capability to antiretroviral drugs","volume":"23","year":"2022","journal-title":"Int. J. Mol. Sci"},{"key":"2026020503293834000_2026.01.25.701611v1.21","doi-asserted-by":"crossref","first-page":"113548","DOI":"10.1016\/j.isci.2025.113548","article-title":"NKp30 and NKG2D contribute to natural killer cell-mediated recognition of HIV-infected cells","volume":"28","year":"2025","journal-title":"iScience"},{"key":"2026020503293834000_2026.01.25.701611v1.22","doi-asserted-by":"crossref","unstructured":"Satheesan, S. et al. HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational antiretroviral therapy. J. Virol. 92, (2018).","DOI":"10.1128\/JVI.02118-17"},{"key":"2026020503293834000_2026.01.25.701611v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27647-0"},{"key":"2026020503293834000_2026.01.25.701611v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2015.05.002"},{"key":"2026020503293834000_2026.01.25.701611v1.25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12977-020-00516-2","article-title":"Benefits and limitations of humanized mice in HIV persistence studies","volume":"17","year":"2020","journal-title":"Retrovirology"},{"key":"2026020503293834000_2026.01.25.701611v1.26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667393"},{"key":"2026020503293834000_2026.01.25.701611v1.27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0516"},{"key":"2026020503293834000_2026.01.25.701611v1.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0684.2004.00057.x"},{"key":"2026020503293834000_2026.01.25.701611v1.29","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0684.2001.d01-54.x"},{"key":"2026020503293834000_2026.01.25.701611v1.30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.18.8210"},{"key":"2026020503293834000_2026.01.25.701611v1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2014.08.003"},{"key":"2026020503293834000_2026.01.25.701611v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2017.07.010"},{"key":"2026020503293834000_2026.01.25.701611v1.33","doi-asserted-by":"publisher","DOI":"10.1093\/ilar\/ilx032"},{"key":"2026020503293834000_2026.01.25.701611v1.34","unstructured":"National Academies of Sciences, Engineering, and Medicine; Division on Earth and Life Studies; Health and Medicine Division; Institute for Laboratory Animal Research; Board on Health Sciences Policy; Committee on the State of the Science and Future Needs for Nonhuman Primate Model Systems, Yost, O. C. , Downey, A. & Ramos, K. S. Current Landscape of Use and Availability of Nonhuman Primates for NIH-Supported Biomedical Research. in Nonhuman Primate Models in Biomedical Research: State of the Science and Future Needs (National Academies Press (US), 2023)."},{"key":"2026020503293834000_2026.01.25.701611v1.35","doi-asserted-by":"publisher","DOI":"10.1038\/nm1295-1320"},{"key":"2026020503293834000_2026.01.25.701611v1.36","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1997.13.461"},{"key":"2026020503293834000_2026.01.25.701611v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00217-5"},{"key":"2026020503293834000_2026.01.25.701611v1.38","doi-asserted-by":"crossref","unstructured":"Soare, A. Y. et al. P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines interleukin-10 (IL-10) and IL-1\u03b2 in a human tonsil explant model. J. Virol. 93, (2019).","DOI":"10.1128\/JVI.01186-18"},{"key":"2026020503293834000_2026.01.25.701611v1.39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/aid.2015.0235","article-title":"Dendritic cells enhance HIV infection of memory CD4(+) T cells in human lymphoid tissues","volume":"32","year":"2016","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"2026020503293834000_2026.01.25.701611v1.40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502174"},{"key":"2026020503293834000_2026.01.25.701611v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.06.087"},{"key":"2026020503293834000_2026.01.25.701611v1.42","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-6-6"},{"key":"2026020503293834000_2026.01.25.701611v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.11.001"},{"key":"2026020503293834000_2026.01.25.701611v1.44","doi-asserted-by":"crossref","first-page":"1172938","DOI":"10.3389\/fimmu.2023.1172938","article-title":"HIV-1 activates oxidative phosphorylation in infected CD4 T cells in a human tonsil explant model","volume":"14","year":"2023","journal-title":"Front. Immunol"},{"key":"2026020503293834000_2026.01.25.701611v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01145-0"},{"key":"2026020503293834000_2026.01.25.701611v1.46","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.7.5255-5264.1999"},{"key":"2026020503293834000_2026.01.25.701611v1.47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01144.x"},{"key":"2026020503293834000_2026.01.25.701611v1.48","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2012.0011"},{"key":"2026020503293834000_2026.01.25.701611v1.49","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12257"},{"key":"2026020503293834000_2026.01.25.701611v1.50","doi-asserted-by":"publisher","DOI":"10.20411\/pai.v1i1.100"},{"key":"2026020503293834000_2026.01.25.701611v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01693-z"},{"key":"2026020503293834000_2026.01.25.701611v1.52","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006924"},{"key":"2026020503293834000_2026.01.25.701611v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2017.12.004"},{"key":"2026020503293834000_2026.01.25.701611v1.54","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01651-9"},{"key":"2026020503293834000_2026.01.25.701611v1.55","doi-asserted-by":"crossref","first-page":"103615","DOI":"10.1016\/j.isci.2021.103615","article-title":"HIV reservoir quantification using cross-subtype multiplex ddPCR","volume":"25","year":"2022","journal-title":"iScience"},{"key":"2026020503293834000_2026.01.25.701611v1.56","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051856"},{"key":"2026020503293834000_2026.01.25.701611v1.57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1414926112"},{"key":"2026020503293834000_2026.01.25.701611v1.58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084318"},{"key":"2026020503293834000_2026.01.25.701611v1.59","doi-asserted-by":"crossref","first-page":"1540932","DOI":"10.3389\/fimmu.2025.1540932","article-title":"HIV controllers: hope for a functional cure","volume":"16","year":"2025","journal-title":"Front. Immunol"},{"key":"2026020503293834000_2026.01.25.701611v1.60","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.MR0718-269R"},{"key":"2026020503293834000_2026.01.25.701611v1.61","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4421"},{"key":"2026020503293834000_2026.01.25.701611v1.62","doi-asserted-by":"crossref","first-page":"103794","DOI":"10.1016\/j.ebiom.2021.103794","article-title":"Implications of the accumulation of CXCR5+ NK cells in lymph nodes of HIV-1 infected patients","volume":"75","year":"2022","journal-title":"EBioMedicine"},{"key":"2026020503293834000_2026.01.25.701611v1.63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.1.350"},{"key":"2026020503293834000_2026.01.25.701611v1.64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/COH.0000000000000819","article-title":"Guiding HIV-1 vaccine development with preclinical nonhuman primate research","volume":"18","year":"2023","journal-title":"Curr. Opin. HIV AIDS"},{"key":"2026020503293834000_2026.01.25.701611v1.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2013.11.022"},{"key":"2026020503293834000_2026.01.25.701611v1.66","doi-asserted-by":"crossref","first-page":"101681","DOI":"10.1016\/j.xpro.2022.101681","article-title":"Protocol for high-throughput reservoir quantification across global HIV subtypes using a cross-subtype intact proviral DNA assay","volume":"3","year":"2022","journal-title":"STAR Protoc"},{"key":"2026020503293834000_2026.01.25.701611v1.67","doi-asserted-by":"crossref","first-page":"100243","DOI":"10.1016\/j.xcrm.2021.100243","article-title":"A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir","volume":"2","year":"2021","journal-title":"Cell Rep. Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.01.25.701611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:29:51Z","timestamp":1770290991000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.01.25.701611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":67,"URL":"https:\/\/doi.org\/10.64898\/2026.01.25.701611","relation":{},"subject":[],"published":{"date-parts":[[2026,1,27]]},"subtype":"preprint"}}